Noblezada, Francisco .
HRN: 26-73-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/05/2025
03/11/2025
IVTT
1.5 G
Q6h
Cap-MR; Sepsis; T/c Intraabdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes